(Q46426269)

22 December 2017

title

Losartan and simvastatin inhibit platelet activation in hypertensive patients (English)

1 reference

22 December 2017

1 reference

1 reference

Shosaku Nomura

1

1 reference

22 December 2017

Akira Shouzu

2

1 reference

22 December 2017

Seitarou Omoto

3

1 reference

22 December 2017

Mitsushige Nishikawa

4

1 reference

22 December 2017

Shirou Fukuhara

5

1 reference

22 December 2017

Toshiji Iwasaka

6

1 reference

22 December 2017

publication date

1 December 2004

1 reference

22 December 2017

Journal of Thrombosis and Thrombolysis

published in

1 reference

22 December 2017

volume

18

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

177-185

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s11239-005-0343-8

exact match

0 references

cites work

Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-005-0343-8

Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-005-0343-8

Simvastatin reduces plasma concentration of high-sensitivity C-reactive protein in type 2 diabetic patients with hyperlipidemia

21 January 2018

1 reference

12 December 2020

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Inhibition of platelet aggregability by losartan in essential hypertension

1 reference

12 December 2020

Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179.

1 reference

12 December 2020

Diabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damage

1 reference

12 December 2020

Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes

1 reference

12 December 2020

National High Blood Pressure Education Program Working Group report on hypertension in diabetes

1 reference

12 December 2020

Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.

1 reference

12 December 2020

In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.

1 reference

12 December 2020

Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease

1 reference

12 December 2020

Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy

1 reference

12 December 2020

Losartan in patients with type 2 diabetes and proteinuria: observations from the RENAAL Study

1 reference

12 December 2020

The hypercoagulable states

1 reference

12 December 2020

Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).

1 reference

12 December 2020

Amyloid beta-protein precursor-rich platelet microparticles in thrombotic disease

1 reference

12 December 2020

Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus

1 reference

12 December 2020

Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes.

1 reference

12 December 2020

AT1-receptor antagonists abolish glomerular MCP-1 expression in a model of mesangial proliferative glomerulonephritis

1 reference

12 December 2020

High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells

1 reference

12 December 2020

Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients

1 reference

12 December 2020

Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation

1 reference

12 December 2020

Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity

1 reference

12 December 2020

HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells

1 reference

12 December 2020

E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress

1 reference

12 December 2020

Microalbuminuria and coronary heart disease in NIDDM: an incidence study.

1 reference

12 December 2020

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

12 December 2020

Statins as potent antiinflammatory drugs

1 reference

12 December 2020

Inhibition of tissue-factor-mediated thrombin generation by simvastatin

1 reference

12 December 2020

Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects

1 reference

12 December 2020

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy

1 reference

12 December 2020

Effect of combining ACE inhibitor and statin in severe experimental nephropathy

1 reference

12 December 2020

Effect of losartan on human platelet activation

1 reference

12 December 2020

Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control

1 reference

12 December 2020

Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes

1 reference

12 December 2020

Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction

1 reference

12 December 2020

NIDDM is the Major Cause of Diabetic End-Stage Renal Disease: More Evidence From a Tri-Ethnic Community

1 reference

12 December 2020

Immune mechanisms of atherosclerosis in diabetes mellitus

1 reference

12 December 2020

Large Platelets Circulate in an Activated State in Diabetes Mellitus

1 reference

12 December 2020

Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation

1 reference

12 December 2020

Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia.

1 reference

12 December 2020

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

12 December 2020

The role of platelets in the development and complications of atherosclerosis

1 reference

12 December 2020

Effect of simvastatin on monocyte adhesion molecule expression in patients with hypercholesterolemia

1 reference

12 December 2020

Function and clinical significance of platelet-derived microparticles

1 reference

12 December 2020

Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.

1 reference

12 December 2020

Progression, remission, regression of chronic renal diseases

1 reference

12 December 2020

Effect of losartan in aging-related endothelial impairment

1 reference

12 December 2020

High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles

1 reference

12 December 2020

Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment

1 reference

12 December 2020

Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia

1 reference

12 December 2020

Simvastatin reduces activation of normal platelets by LDL isolated from patients with familial hypercholesterolaemia and familial defective apolipoprotein B

1 reference

12 December 2020

Rho-GTPase-dependent platelet-neutrophil interaction affected by HMG-CoA reductase inhibition with altered adenosine nucleotide release and function

1 reference

12 December 2020

Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release

1 reference

12 December 2020

10.1007/S11239-005-0343-8

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017